|
|
||||||||
Cutting Edge |




,
* Department of Medicine, Division of Gastroenterology, and
Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD 21201; and
Veterans Affairs Maryland Health Care System, Baltimore, MD 21201
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
A major part of innate immunity is the up-regulation of inducible NO synthase (iNOS)3 (3). Increased iNOS expression has been demonstrated in H. pylori gastritis tissues, with localization in both epithelium and lamina propria (8). This expression has been linked to epithelial cell injury (9) and apoptosis (10). Moreover, we have previously demonstrated that H. pylori directly stimulates murine macrophage NO production through the induction of iNOS expression (11, 12). NO generation by macrophages is activated by intact bacteria or by soluble components of H. pylori and does not require the presence of H. pylori LPS (11, 13). In addition, H. pylori medium filtrates cause macrophage NO synthesis (14), supporting the hypothesis that factors released from H. pylori are activators of iNOS.
The aim of this study was to determine whether any of the major proteins released by H. pylori induce iNOS expression and activity. For this purpose, we used mutant strains deficient in virulence and survival factors of H. pylori. When intact bacteria were separated from macrophages, or when water-soluble extracts were used, a mutant strain of H. pylori lacking urease failed to induce iNOS mRNA expression, iNOS protein, or NO production, whereas mutant strains deficient in vacA, cagA, or picB had no loss of iNOS induction compared with wild-type (WT) strains. In addition, activation of iNOS-derived NO synthesis by macrophages was reproduced by recombinant urease. Therefore, we suggest that the induction of iNOS by H. pylori urease represents a new and important immunologic role for this enzyme in the pathogenesis of H. pylori gastritis.
| Materials and Methods |
|---|
|
|
|---|
All the reagents for cell culture and RNA analysis were obtained from Life Technologies (Gaithersburg, MD). Recombinant H. pylori urease was obtained from Orovax (Cambridge, MA) and used as described (15). Endotoxin level in the urease preparation was measured by Limulus amebocyte lysate testing at BioWhittaker (Walkersville, MD); there were 6.5 pg of LPS per microgram of urease. All other chemicals were from Sigma (St. Louis, MO).
Bacteria
H. pylori strains 3401 and 26695 were used. H. pylori 3401, and the isogenic vacA, cagA, picB, and ureA mutants were obtained from M. J. Blaser, Vanderbilt University (16). H. pylori 26695 and the ureA-deficient mutant (17) were provided by H. L. T. Mobley (University of Maryland, Baltimore, MD). It has been shown that ureA deletion results in elimination of total urease protein (17). WT or mutant bacteria were grown on Brucella agar plates containing 10% sheep blood under microaerobic conditions for an equal number of passages. For the experiments, H. pylori were harvested from plates, washed twice, and suspended in PBS. Bacteria concentrations were then evaluated by the determination of OD600. Water extracts of bacteria were obtained, and protein concentration was determined as reported (12).
Mice, cells, and culture conditions
The murine macrophage cell line RAW 264.7 was maintained and cocultured with H. pylori as previously reported (18). H. pylori was added to macrophages with a multiplicity of infection (MOI) from 10 to 100. To separate bacteria from macrophages, filter supports (0.4-µm pore size; Transwell; Corning, Corning, NY) were used. Cultures were also performed in the presence or absence of water extracts of H. pylori and recombinant urease. Peritoneal macrophages from C57BL/6 mice (The Jackson Laboratory, Bar Harbor, ME) were isolated as previously described (19) and cultured in complete DMEM.
mRNA analysis
RAW 264.7 macrophages were cocultured with H. pylori, with or without filter supports. After incubations, cells were washed twice with PBS, and total RNA was isolated using TRIzol reagent. Reverse transcription, PCR cycle conditions, and primer sequences were as described (18). PCR products were run on 2% agarose gels. Ethidium bromide-stained bands were visualized under UV light and photographed with a digital gel documentation system (EDAS 290 and 1D software; Kodak Digital Science, Rochester, NY). Northern blot analysis of total RNA (10 µg/lane) was performed as previously described (11), using a 32P random primer-labeled cDNA probe for murine iNOS (Cayman Chemical, Ann Arbor, MI) and a cDNA probe (1.1 kb) for GAPDH (Clontech, Palo Alto, CA). Densitometric analysis of band intensity was determined using NIH Image version 1.62 (http://rsb.info.nih.gov/nih-image/).
Western blot analysis
After coculture with H. pylori, macrophages were washed and lysed in 250 µl of PBS containing 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 100 µg/ml PMSF, 50 µg/ml aprotinin, and 1 mM sodium orthovanadate. Soluble proteins from macrophages (100 µg/lane) or from H. pylori water extracts (25 µg/lane) were separated by SDS-PAGE on 10% gels, and transferred onto Immobilon-P membranes (Millipore, Bedford, MA) by electroblotting. Membranes were blocked using PBS containing 0.1% Tween and 5% nonfat dry milk overnight at 4°C. Polyclonal Ab to murine iNOS (1/2,000; BD Transduction Laboratories, Lexington, KY) or to H. pylori UreB (1/50,000; H. L. T. Mobley), and a donkey anti-rabbit Ab conjugated to HRP (1/2,000; Amersham Pharmacia Biotech, Piscataway, NJ) were used, each for 1 h at room temperature. Chemiluminescent detection was performed using the SuperSignal West Pico Chemiluminescent Substrate (Pierce, Rockford, IL) and exposure to Hyperfilm ECL (Amersham, Little Chalfont, U.K.).
Measurement of NO concentration
The concentration of the oxidized product of NO, nitrite (NO2-), was assessed by the Griess reaction, as described (11, 12).
Statistical analysis
Quantitative data are shown as the mean ± SEM. For comparisons between multiple groups the Student-Newman-Keuls test was used, and for single comparisons between two groups the Students t test was used.
| Results |
|---|
|
|
|---|
To determine the potential roles of the proteins VacA, CagA, PicB,
and urease on iNOS activation in RAW 264.7 cells, different strains of
H. pylori were added to macrophages, with or without
Transwell filters. When there was contact between macrophages and
bacteria (Fig. 1
, left), there
was no difference in the degree of up-regulation of iNOS mRNA (Fig. 1
, A and B), iNOS protein (Fig. 1
C), and
NO production (Fig. 1
D) between 3401 WT,
vacA-, cagA-,
ureA-, or
picB- strains.
|
Lack of induction of macrophage NO2- generation with ureA- H. pylori at varying MOI
To further assess differences in iNOS stimulation by WT and
ureA- H. pylori, we analyzed
the effects of bacterial concentration and incubation time on
macrophage NO2- generation. At
a time point of 24 h (Fig. 2
A), a concentration-dependent
effect of bacterial MOI on macrophage
NO2- release was observed with
H. pylori WT stimulation. There was a significant decrease
in stimulated NO2- release by
the ureA- vs WT strain at each MOI of 25
or greater. After 48 h, high levels of
NO2- were detected in the
cocultures with H. pylori WT, even at an MOI of 10 (Fig. 2
B). There was a significant decrease of stimulated
NO2- by the
ureA- strain vs the WT at each MOI tested
from 10 to 100. As an example,
NO2- concentration in
supernatants was inhibited by 7.8- ± 0.2-fold at an MOI of
50.
|
A concentration-dependent increase of
NO2- generation was observed
when macrophages were stimulated by water extracts of WT,
vacA-, cagA-,
or picB- strains (Fig. 3
A). Consistent with the
results in the Transwell experiments in Figs. 1
and 2
, the water
extract of the ureA- strain did not induce
any NO2- production at 2.5 or
5.0 µg/ml. At a protein concentration of 10 µg/ml,
NO2- levels were significantly
attenuated by 68, 61, 51, and 64% when compared with WT,
vacA-, cagA-,
or picB- mutants, respectively. Similarly,
there was a marked induction of
NO2- release by resident
peritoneal macrophages in response to WT water extract, which was
abolished when the ureA- water extract was
used (Fig. 3
B). Fig. 3
C demonstrates that urease
protein was detected in the water extract of WT and of
vacA-, cagA-,
or picB- mutants, but not in the soluble
fraction of the ureA- mutant.
|
Because of our findings of reduced iNOS inducing activity by the
ureA- mutant strain, we tested the ability
of H. pylori urease to activate macrophage iNOS. In RAW
264.7 cells exposed to recombinant urease, iNOS mRNA expression was
up-regulated (Fig. 4
A). A
concentration-dependent increase in macrophage
NO2- generation induced by
H. pylori urease is shown in Fig. 4
B. This
increase was not attributable to LPS contamination of the recombinant
urease, because Escherichia coli LPS added at the amount of
LPS in the urease preparation (see Materials and Methods)
failed to stimulate NO2-
production (data not shown).
|
| Discussion |
|---|
|
|
|---|
5 µg/ml in our
experimental conditions), but at higher concentrations other factors
may be capable of inducing iNOS. H. pylori secretes or releases numerous proteins in the extracellular environment. Some of them, such as catalase and superoxide dismutase, are directly involved in the defense of the bacteria against reactive oxygen species (24). In culture medium, H. pylori secretes VacA rapidly by a specific transporter (25). When H. pylori is in contact with gastric epithelial cells, CagA protein is injected into the host cells by a type IV secretion system (3). However, there is no evidence of secretion of CagA into the extracellular environment. Similarly, no specific secretion mechanism has been described for the picB product. In contrast, there is evidence for a specific secretion system for urease (26). Additionally, it should be recognized that release of H. pylori cytoplasmic proteins can occur by autolysis of the bacteria (27). Urease has been detected in the lamina propria of gastric antrum from patients with H. pylori gastritis (28), indicating that urease release occurs in vivo and is capable of reaching lamina propria immune cells beneath the epithelium, as we have modeled in the current study. In a previous report, it was suggested that contact was required for murine macrophage J774A.1 iNOS activation (13), because when well inserts were used, no iNOS induction was observed. However, iNOS mRNA expression was assessed only at 4 h after H. pylori stimulation, and at this time point no expression was found in our experiments (data not shown), even at an MOI of 100. It is likely that a longer time for coculture is required to allow urease to be released and then activate the macrophages.
Although the main role of H. pylori urease is to protect the
bacteria from acidic conditions through the formation of ammonia,
urease possesses other properties. H. pylori urease exhibits
chemotactic activity for human monocytes (28) and is a
strong activator of production of the Th1 cytokines IFN-
and
IL-12p40 (15) as well as IL-1
, IL-6, and TNF-
(29) by PBMC.
Macrophage-derived NO can be a potent inhibitor of H. pylori growth (12), and it can also contribute to mucosal damage. Both bacterial killing and intense tissue injury are events that should limit the ultimate survival of H. pylori in the stomach of the host. Thus, an intriguing question is raised: "Why should the essential survival factor, urease, stimulate macrophage iNOS expression?" One possibility is that this is a necessary price for the bacteria to pay, because the bacteria must produce and release large quantities of urease, and the host can have both nonspecific and adaptive responses to this protein. Thus, there is a balance between the host and the pathogen. In addition, H. pylori has elaborated numerous strategies to escape the effects of NO (12) and/or peroxynitrite (30). Because NO and its metabolites have been implicated in gastric carcinogenesis (31), it is important to realize that the chronic expression of iNOS due to urease released from persistent H. pylori infection in the stomach may be an important contributor to the risk for H. pylori-associated gastric cancer.
| Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. Keith T. Wilson, University of Maryland School of Medicine, 22 South Greene Street, Room N3W62, Baltimore, MD 21201. E-mail address: kwilson{at}umaryland.edu ![]()
3 Abbreviations used in this paper: iNOS, inducible NO synthase; WT, wild type; MOI, multiplicity of infection. ![]()
Received for publication March 29, 2002. Accepted for publication April 29, 2002.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. P. Celli, B. S. Turner, N. H. Afdhal, S. Keates, I. Ghiran, C. P. Kelly, R. H. Ewoldt, G. H. McKinley, P. So, S. Erramilli, et al. Helicobacter pylori moves through mucus by reducing mucin viscoelasticity PNAS, August 25, 2009; 106(34): 14321 - 14326. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Chiapello, J. L. Baronetti, A. P. Garro, M. F. Spesso, and D. T. Masih Cryptococcus neoformans glucuronoxylomannan induces macrophage apoptosis mediated by nitric oxide in a caspase-independent pathway Int. Immunol., December 1, 2008; 20(12): 1527 - 1541. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Chaturvedi, M. Asim, N. D. Lewis, H. M. S. Algood, T. L. Cover, P. Y. Kim, and K. T. Wilson L-Arginine Availability Regulates Inducible Nitric Oxide Synthase-Dependent Host Defense against Helicobacter pylori Infect. Immun., September 1, 2007; 75(9): 4305 - 4315. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Schwartz and L.-A. H. Allen Role of urease in megasome formation and Helicobacter pylori survival in macrophages J. Leukoc. Biol., June 1, 2006; 79(6): 1214 - 1225. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Das, G. Suarez, E. J. Beswick, J. C. Sierra, D. Y. Graham, and V. E. Reyes Expression of B7-H1 on Gastric Epithelial Cells: Its Potential Role in Regulating T Cells during Helicobacter pylori Infection. J. Immunol., March 1, 2006; 176(5): 3000 - 3009. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Beswick, I. V. Pinchuk, K. Minch, G. Suarez, J. C. Sierra, Y. Yamaoka, and V. E. Reyes The Helicobacter pylori Urease B Subunit Binds to CD74 on Gastric Epithelial Cells and Induces NF-{kappa}B Activation and Interleukin-8 Production Infect. Immun., February 1, 2006; 74(2): 1148 - 1155. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Cheng, R. Chaturvedi, M. Asim, F. I. Bussiere, H. Xu, R. A. Casero Jr., and K. T. Wilson Helicobacter pylori-induced Macrophage Apoptosis Requires Activation of Ornithine Decarboxylase by c-Myc J. Biol. Chem., June 10, 2005; 280(23): 22492 - 22496. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. I. Bussiere, R. Chaturvedi, Y. Cheng, A. P. Gobert, M. Asim, D. R. Blumberg, H. Xu, P. Y. Kim, A. Hacker, R. A. Casero Jr., et al. Spermine Causes Loss of Innate Immune Response to Helicobacter pylori by Inhibition of Inducible Nitric-oxide Synthase Translation J. Biol. Chem., January 28, 2005; 280(4): 2409 - 2412. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Chaturvedi, Y. Cheng, M. Asim, F. I. Bussiere, H. Xu, A. P. Gobert, A. Hacker, R. A. Casero Jr., and K. T. Wilson Induction of Polyamine Oxidase 1 by Helicobacter pylori Causes Macrophage Apoptosis by Hydrogen Peroxide Release and Mitochondrial Membrane Depolarization J. Biol. Chem., September 17, 2004; 279(38): 40161 - 40173. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Duleu, P. Vincendeau, P. Courtois, S. Semballa, I. Lagroye, S. Daulouede, J.-L. Boucher, K. T. Wilson, B. Veyret, and A. P. Gobert Mouse Strain Susceptibility to Trypanosome Infection: An Arginase-Dependent Effect J. Immunol., May 15, 2004; 172(10): 6298 - 6303. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tan and D. E. Berg Motility of Urease-Deficient Derivatives of Helicobacter pylori J. Bacteriol., February 1, 2004; 186(3): 885 - 888. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Gobert, J.-C. Bambou, C. Werts, V. Balloy, M. Chignard, A. P. Moran, and R. L. Ferrero Helicobacter pylori Heat Shock Protein 60 Mediates Interleukin-6 Production by Macrophages via a Toll-like Receptor (TLR)-2-, TLR-4-, and Myeloid Differentiation Factor 88-independent Mechanism J. Biol. Chem., January 2, 2004; 279(1): 245 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Meyer, K. S. Ramanujam, A. P. Gobert, S. P. James, and K. T. Wilson Cutting Edge: Cyclooxygenase-2 Activation Suppresses Th1 Polarization in Response to Helicobacter pylori J. Immunol., October 15, 2003; 171(8): 3913 - 3917. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |